Comparison of methods of surfactant administration in premature infants.
Not Applicable
- Conditions
- Health Condition 1: P220- Respiratory distress syndrome of newborn
- Registration Number
- CTRI/2023/07/055841
- Lead Sponsor
- Government medical college and hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Spontaneously breathing preterm neonates between 26 and 35 weeks of gestation who will require surfactant therapy for Respiratory Distress Syndrome.
Exclusion Criteria
Babies who had a major congenital anomaly, with hemodynamic instability requiring inotropic support prior to randomization, had suffered severe asphyxia (Apgar score less than 4 at 5 minutes and/or requiring positive pressure ventilation for more than 2 minutes) and those who were already intubated at the time of first surfactant dose.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method